Bb Biotech Ag
(ETR) BBZA
Bb Biotech Ag Financials at a Glance
Market Cap
$2.61B
Revenue (TTM)
$176.15M
Net Income (TTM)
$438.69M
EPS (TTM)
$11.31
P/E Ratio
4.18
Dividend
$2.47
Beta (Volatility)
-0.04 (Low)
Dividend
$2.47
Beta (Volatility)
-0.04 (Low)
Price
$46.15
Volume
6,875
Open
$47.60
Price
$46.15
Volume
6,875
Open
$47.60
Previous Close
$46.15
Daily Range
$46.15 - $47.70
52-Week Range
$25.65 - $53.50
Dividend
$2.47
Beta (Volatility)
-0.04 (Low)
Price
$46.15
Volume
6,875
Open
$47.60
Previous Close
$46.15
Daily Range
$46.15 - $47.70
52-Week Range
$25.65 - $53.50
BBZA News
BBZA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bb Biotech Ag
BBZA Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
30%
Net Income Margin
2%
Return on Equity
23%
Return on Capital
-2%
Return on Assets
-16%
Earnings Yield
23.92%
Dividend Yield
0.05%
Payout Ratio
-22.45%
Stock Overview
Market Cap
$2.61B
Shares Outstanding
55.15M
Volume
6.88K
Short Interest
0.00%
Avg. Volume
10.55K
Financials (TTM)
Gross Profit
$111.63M
Operating Income
$84.40M
EBITDA
$80.24M
Operating Cash Flow
$309.14M
Capital Expenditure
$0.00
Free Cash Flow
$309.14M
Cash & ST Invst.
$99.41M
Total Debt
$0.00
Bb Biotech Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$93.71M
-292943.8%
Gross Profit
$93.71M
-292943.8%
Gross Margin
100.00%
N/A
Market Cap
$2.61B
N/A
Market Cap/Employee
$260.58M
N/A
Employees
10
N/A
Net Income
$100.24M
-15.1%
EBITDA
$0.00
+100.0%
Quarterly Fundamentals
Net Cash
$99.41M
+136.5%
Accounts Receivable
$5.51M
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-15.75%
N/A
Return on Invested Capital
-1.87%
N/A
Free Cash Flow
$59.96M
-323.9%
Operating Cash Flow
$59.96M
-323.9%